Structural and regulatory characterization of the placental epigenome at its maternal interface

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Chu, Tianjiao ^a,b   Handley, Daniel ^a,b   Bunce, Kimberly ^a,b   Surti, Urvashi ^a   Hogge, W Allen ^a   Peters, David G ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHORION VILLUS SAMPLING; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 21; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; FEMALE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENETIC VARIABILITY; GENOME ANALYSIS; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; MATERNAL BLOOD; MICROARRAY ANALYSIS; PLACENTA DEVELOPMENT; PROMOTER REGION; STRUCTURE ACTIVITY RELATION; TISSUE SPECIFICITY; BLOOD; CHORION VILLUS; COMPARATIVE STUDY; DNA MICROARRAY; EPIGENETICS; ERYTHROCYTE; FIRST TRIMESTER PREGNANCY; GENE; GENE EXPRESSION PROFILING; GENETICS; HUMAN GENOME; METABOLISM; METHODOLOGY; PHYSIOLOGY; PLACENTA; PREGNANCY; REGULATORY SEQUENCE;

CHORIONIC VILLI; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; ERYTHROCYTES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES; GENOME, HUMAN; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 79952019267     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014723     Document Type: Article

References (39)

1. Tost J, (2009) DNA Methylation: An Introduction to the Biology and the Disease-Associated Changes of a Promising Biomarker. Mol Biotechnol.
2. Fauque P, Jouannet P, Lesaffre C, Ripoche MA, Dandolo L, et al. (2007) Assisted Reproductive Technology affects developmental kinetics, H19 Imprinting Control Region methylation and H19 gene expression in individual mouse embryos. BMC Dev Biol 7: 116.
3. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, et al. (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 102: 10604-10609.
4. Waterland RA, Jirtle RL, (2003) Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23: 5293-5300.
5. Tang WY, Ho SM, (2007) Epigenetic reprogramming and imprinting in origins of disease. Rev Endocr Metab Disord 8: 173-182.
6. Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, et al. (2007) Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 67: 876-880.
7. Michaud EJ, van Vugt MJ, Bultman SJ, Sweet HO, Davisson MT, et al. (1994) Differential expression of a new dominant agouti allele (Aiapy) is correlated with methylation state and is influenced by parental lineage. Genes Dev 8: 1463-1472.
8. Jablonka E, Lamb MJ, (1989) The inheritance of acquired epigenetic variations. J Theor Biol 139: 69-83.
9. Robertson KD, (2005) DNA methylation and human disease. Nat Rev Genet 6: 597-610.
10. Ball MP, Li JB, Gao Y, Lee JH, LeProust EM, et al. (2009) Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 27: 361-368.
11. van Vliet J, Oates NA, Whitelaw E, (2007) Epigenetic mechanisms in the context of complex diseases. Cell Mol Life Sci 64: 1531-1538.
12. Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, et al. (2006) Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 15: 3132-3145.
13. Anway MD, Cupp AS, Uzumcu M, Skinner MK, (2005) Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308: 1466-1469.
14. Anway MD, Skinner MK, (2008) Epigenetic programming of the germ line: effects of endocrine disruptors on the development of transgenerational disease. Reprod Biomed Online 16: 23-25.
15. Guo L, Choufani S, Ferreira J, Smith A, Chitayat D, et al. (2008) Altered gene expression and methylation of the human chromosome 11 imprinted region in small for gestational age (SGA) placentae. Dev Biol 320: 79-91.
16. Maccani MA, Marsit CJ, (2009) Epigenetics in the placenta. Am J Reprod Immunol 62: 78-89.
17. Roberts JM, Hubel CA, (2008) The Two Stage Model of Preeclampsia: Variations on the Theme. Placenta.
18. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, et al. (2006) Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52: 2211-2218.
19. Lo YM, (2005) Recent advances in fetal nucleic acids in maternal plasma. J Histochem Cytochem 53: 293-296.
20. Tong YK, Ding C, Chiu RW, Gerovassili A, Chim SS, et al. (2006) Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. Clin Chem 52: 2194-2202.
21. Leung TN, Zhang J, Lau TK, Chan LY, Lo YM, (2001) Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 47: 137-139.
22. Iovannisci DM, Ha TT, Shaw GM, (2006) Recovery of genomic DNA from residual frozen archival blood clots suitable for amplification and use in genotyping assays. Genet Test 10: 44-49.
23. Hastie T, Tibshirani R, (1995) Generalized additive models for medical research. Stat Methods Med Res 4: 187-196.
24. Chu T, Burke B, Bunce K, Surti U, Allen Hogge W, et al. (2009) A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease. Prenat Diagn 29: 1020-1030.
25. Holtan SG, Creedon DJ, Haluska P, Markovic SN, (2009) Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents. Mayo Clin Proc 84: 985-1000.
26. Pfister S, Schlaeger C, Mendrzyk F, Wittmann A, Benner A, et al. (2007) Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma. Nucleic Acids Res 35: e51.
27. Yu J, Zhu T, Wang Z, Zhang H, Qian Z, et al. (2007) A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin Cancer Res 13: 7296-7304.
28. Pike BL, Greiner TC, Wang X, Weisenburger DD, Hsu YH, et al. (2008) DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia 22: 1035-1043.
29. Guo M, Akiyama Y, House MG, Hooker CM, Heath E, et al. (2004) Hypermethylation of the GATA genes in lung cancer. Clin Cancer Res 10: 7917-7924.
30. Tsou JA, Galler JS, Siegmund KD, Laird PW, Turla S, et al. (2007) Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma. Mol Cancer 6: 70.
31. Chu T, Burke B, Bunce K, Surti U, Allen Hogge W, et al. (2009) A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease. Prenat Diagn.
32. Fazzari MJ, Greally JM, (2004) Epigenomics: beyond CpG islands. Nat Rev Genet 5: 446-455.
33. Founds SA, Conley YP, Lyons-Weiler JF, Jeyabalan A, Allen Hogge W, et al. (2009) Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta 30: 15-24.
34. Rakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, et al. (2008) An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res 18: 1518-1529.
35. Farthing CR, Ficz G, Ng RK, Chan CF, Andrews S, et al. (2008) Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes. PLoS Genet 4: e1000116.
36. Uy GD, Downs KM, Gardner RL, (2002) Inhibition of trophoblast stem cell potential in chorionic ectoderm coincides with occlusion of the ectoplacental cavity in the mouse. Development 129: 3913-3924.
37. Papageorgiou EA, Fiegler H, Rakyan V, Beck S, Hulten M, et al. (2009) Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol 174: 1609-1618.
38. Rakyan VK, Hildmann T, Novik KL, Lewin J, Tost J, et al. (2004) DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project. PLoS Biol 2: e405.
39. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, et al. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39: 457-466.